Abu Dhabi Commercial Bank PJSC (“ADCB” or “the Bank”) welcomes the approval by creditors of NMC Group (“NMC” or “the Company”) of the restructuring of the Company’s debt and issuance of exit instruments to its creditors.
As a significant creditor to NMC, ADCB took proactive actions from February 2020 onwards initially taking NMC’s parent company in the UK into administration, which ultimately led to the Company filing for voluntary administration in ADGM, a course of action that was identified by the Company and its advisors as the most suitable route to ensure rescue and timely turnaround of the Company. Such actions also ensured operational continuity for patients, healthcare workers and other stakeholders throughout the global pandemic period. These proactive approaches were taken in response to several developments at NMC, including the revelation of previously undisclosed liabilities of over US$ 4 billion.
ADCB has worked closely with other creditors to support the joint administrators of the Company, who prepared a three-year business plan to create and maximise value at the Company’s core operations, divest non-core assets, reduce debt and ensure an orderly restructuring process.
In line with this supportive approach, the Bank participated in the Company’s Administration Funding Facility (“AFF”) to underpin the implementation of the business plan and its restructuring process. In consideration of the participation in the AFF, the participants were granted elevation and conversion rights for an amount equivalent to their respective AFF participation. Following the exercise of these rights ADCB is expected to receive approximately 39% of transferable exit instruments in a new US$2.25 billion facility, a debt claim sized to the expected future value of NMC.
Participants in the exit instruments will receive interest payment for the facility, which will ultimately be repaid from the proceeds generated from a sale of the underlying business at a later stage. There are further possibilities for the participants to benefit from any rise in the valuation of the NMC business as well as any recoveries made by the Company from its ongoing litigation strategies. Given this material progress in restructuring, the Bank considers the provisions and interest in suspense for NMC recorded to date to be at an appropriate level.
As a responsible stakeholder in NMC, ADCB takes a long-term view of its interests in the Company and will continue to take a supportive approach to ensure the provision of high- quality medical care for patients across the region and to maximise value. ADCB will appoint three of the seven non-executive directors that participants in the exit instruments will select to the new NMC Holdco’s Board of Directors.
-Ends-
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
